Modulation of early inflammatory reactions to promote engraftment and function of transplanted pancreatic islets in autoimmune diabetes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

We acknowledge that successful long-term islet survival in the liver and immune tolerance to intrahepatic islet antigens are highly dependent upon the initial inflammatory and priming events that occur at this site. Thromboembolic and necroinflammatory events occurring in the liver early after portal vein islet transplantation are thought to reduce the total islet mass by up to 75%. The magnitude of such loss represents a major factor necessitating the extremely large number of islets needed to achieve normoglycemia. A better understanding and control of these events - including their likely support to effector immune responses - are required if we are to develop ways to prevent them, improve intrahepatic islet engraftment, and achieve long-term tolerance.

Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Pages725-747
Number of pages23
Volume654
DOIs
Publication statusPublished - 2010

Publication series

NameAdvances in Experimental Medicine and Biology
Volume654
ISSN (Print)00652598

    Fingerprint

Keywords

  • Instant blood-mediated inflammatory reaction
  • Pancreatic islet transplantation
  • Type 1 diabetes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this